EI
VYGR icon

Ethic Inc’s Voyager Therapeutics VYGR Stock Holding History

Ethic Inc’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45K Sell
12,866
-7,694
-37% -$29.2K ﹤0.01% 1352
2026
Q1 		$79.4K Sell
20,560
-16,178
-44% -$63.7K ﹤0.01% 1205
2025
Q4 		$144K Sell
36,738
-1,615
-4% -$7.14K ﹤0.01% 1152
2025
Q3 		$179K Sell
38,353
-3,064
-7% -$11.1K ﹤0.01% 1127
2025
Q2 		$123K Buy
+41,417
New +$134K ﹤0.01% 1156

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ethic Inc's VYGR Position: Q2 2026 in Review

Ethic Inc reduced its Voyager Therapeutics (VYGR) stake by 37% in Q2 2026, selling an estimated $29.2K and leaving 12,866 shares worth $45K. The position accounts for ﹤0.01% of the portfolio, ranked #1352.

Ethic Inc first reported a position in VYGR in Q2 2025 and has held it in 5 quarters since. The position peaked at $179K in Q3 2025. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Ethic Inc held 12,866 shares of Voyager Therapeutics worth $45K as of Q2 2026.
  • Ethic Inc sold 7,694 Voyager Therapeutics shares in Q2 2026, an estimated $29.2K.
  • Voyager Therapeutics made up ﹤0.01% of Ethic Inc's portfolio in Q2 2026, its #1352 holding.
  • Ethic Inc first reported a position in Voyager Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Ethic Inc's Voyager Therapeutics position peaked at $179K in Q3 2025.
  • 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.